Nubank Joins the Ibovespa: What the B3 Rule Change Means for ROXO34 Relevance4,0
Intermediate PTENES

Nubank Joins the Ibovespa: What the B3 Rule Change Means for ROXO34

The B3 is opening its benchmark index to Brazilian BDRs starting in May 2027, triggering a wave of passive inflows into Nubank and JBS.

Yes, Nubank is in line to join the Ibovespa. Brazil's B3 stock exchange announced on 11/17 that the index will accept BDRs from Brazilian companies starting in May 2027, and the ROXO34 BDR (traded as ROXO34F in the fractional market) is one of four securities that would pass the filter today, alongside the JBSS32 stock. For holders of both, this means a one-time wave of buying from index-tracking funds. The flow is real, but small compared to the factors that actually move prices.

What Happened to ROXO34 and JBSS32 on the B3?

The exchange has changed the rules for its flagship index. According to Luiz Masagão, Vice President of Products and Clients at the B3, the Ibovespa will include BDRs in its composition beginning in May. This marks the first methodological overhaul of the Ibovespa since 2013, broadening the pool of eligible assets beyond domestic stocks and units listed directly on the B3. Until now, none of these companies qualified because the rules required a primary listing in Brazil.

Based on the exchange's own simulations, JBS, Nu Holdings, XP Inc., and Inter & Co. are eligible for inclusion, but the final portfolio composition will only be confirmed during the official rebalancing. The door is not open to every depositary receipt: foreign BDRs, such as Apple's, will remain excluded. To determine if a company is Brazilian, the B3 will evaluate where its revenues, assets, executive headquarters, and employees are located, alongside its operating history. Furthermore, liquidity is measured exclusively by trading volume on the B3, not abroad. Nubank's volume in New York does not count; only the activity generated by ROXO34 locally matters.

Inclusion will be gradual and subject to caps. In May 2027, approved BDRs will enter the index with half the weight calculated under the standard methodology: if a BDR's calculated weight is 2%, its initial weighting will be 1%. Full weighting takes effect during the September 2027 rebalancing. The combined weight of all BDRs cannot exceed 10% of the index, matching the cap applied to pension fund exposure for these assets. The remaining question is how much capital that actually directs to each ticker. Initial estimates are already available.

How Much Capital Will Flow into ROXO34 Following Ibovespa Inclusion?

XP simulated the portfolio under the new rules. According to their estimates, the inclusion of the four BDRs would generate more than R$ 1.1 billion in purchases by passive investors, with R$ 443 million directed to ROXO34, approximately R$ 327 million to JBSS32, and R$ 292 million to XPBR31.

To put that in perspective: ROXO34 averaged R$ 206.6 million in daily trading volume in October 2026. The estimated buying pressure equals just over two days of normal trading volume (443 ÷ 206.6 ≈ 2.1). Because the inclusion is split between May and September, it accounts for roughly one day of trading volume in each phase (our estimate).

Nubank (ROXO34)1.52%
JBS (JBSS32)1.12%
XP (XPBR31)1.00%
Inter (INBR32)0.31%

The chart illustrates each security's weight in the Ibovespa under XP's simulation, assuming full implementation of the new rules. Combined, the four assets account for 3.95%, less than half of the overall cap. This suggests the limit will not pressure any constituent initially.

This figure falls well short of earlier mid-year projections. When the reform was still under review, Bradesco BBI estimated additional demand of around R$ 13 billion in purchases, concentrated in Nubank and Mercado Libre. Mercado Libre did not make the B3's final list of four, and XP's calculation is more than ten times smaller. Investors who bought ROXO34 on expectations of a massive passive-flow wave should temper their expectations. A capital flow of this size cannot single-handedly sustain an investment thesis. So what does?

Is ROXO34 Worth Buying Just for the Ibovespa?

Not on that basis alone. Index inclusion is a secondary detail compared to fundamentals, and the third-quarter earnings report presented a mixed picture. The stock approaches this news well below its peak: ROXO34 shares started the year around R$ 15.48 and sit at R$ 11.89, a decline of roughly 23% in 2026. Part of that pressure arrived in September amid rumors regarding Monzo, which we analyzed in Nubank's drop following takeover talks with the British bank.

  • Record profit: US$ 1.091 billion in the third quarter of 2026, up 31% year-over-year, excluding currency effects.
  • Banking license: On 11/13, Nubank announced it received authorization from Brazil's central bank to operate as a full bank locally, resolving a regulatory hurdle.
  • Higher liquidity: Index-tracking funds are required to hold the asset, increasing the baseline of permanent buyers for ROXO34.
  • Rising defaults: Loans past due by more than 90 days climbed to 7.3%, compared to 6.9% in the second quarter, while credit costs neared US$ 1.8 billion, up 73% year-over-year.
  • Priced-in flows: Fund buying occurs only in May and September 2027, and the market tends to front-run these events. Buying now means competing with everyone else for that gain.
  • FX and taxes: Real-denominated prices depend on the exchange rate, and unlike local stocks, BDRs do not benefit from capital gains tax exemptions for monthly sales below R$ 20,000.

For JBS, the situation is different: the stock does not need new buyers; it needs earnings growth.

What Changes for JBSS32 Stock?

Very little, and the news arrives at a challenging time for the stock. According to XP's figures, JBS would hold the second-largest weight among BDRs, capturing the R$ 327 million in passive inflows mentioned earlier. Data compiled by Eleven Financial shows that the four securities averaged over R$ 50 million in daily trading volume over the past three months. If JBSS32 trades near that floor, the inflows would equal at most six to seven days of trading volume, split across two phases (our estimate). While more significant than Nubank's impact, it does not alter the fundamental outlook.

The primary headwind for JBS is the cattle cycle. In our analysis of third-quarter earnings, we highlighted a 71% profit drop year-over-year. Days later, the stock fell 7.8% after BTG Pactual cut its 2027 earnings forecast, as detailed in our coverage of BTG's commentary on Flora and the company's acquisition pace. Our 11/16 valuation model, calculated at a share price of R$ 68.57, maintains an "avoid" rating with low confidence. The B3 announcement does little to change that assessment.

What This Means for Holders of ROXO34 or JBSS32

Investors do not need to take action right now. There are no ticker changes, share conversions, or corporate actions affecting custodial accounts: the security remains identical and simply becomes part of an index. The likely benefits are improved liquidity and additional fund buying in May and September 2027. The decision to hold or sell still depends entirely on Nubank's delinquency trends and JBS's profit margins.

There is also another side to the equation. According to David Beker of BofA, the rebalancing will trigger capital outflows from current index constituents into BDRs, causing a localized impact. Because BDRs will account for no more than 4% of the index, the resulting dilution for existing Ibovespa stocks is minimal. For investors holding an Ibovespa fund or ETF, the advantage is gaining exposure to Nubank and JBS without having purchased them directly.

ROXO34F, Dividends, and Taxes: Common Questions from Buyers

What is ROXO34F? It is the ticker for the fractional market. ROXO34 trades in standard trading lots as well as through the fractional market (ROXO34F), which allows for smaller position sizes. However, brokerages note that the "F" suffix is largely unnecessary: when the B3 adjusted ETF trading lots, it did the same for BDRs, making the standard trading lot a single unit. In practice, investors can buy a single unit simply by entering ROXO34. On certain platforms, adding the "F" may trigger a "suspended" message. Sources vary regarding the utility of the fractional code; it is worth testing on your home broker platform. Each unit represents a fraction of the share traded in the U.S.: one ROXO34 corresponds to 1/6 of a Nu Holdings share.

How many times per year does ROXO34 pay dividends? None. Over the past year, the stock distributed R$ 0.00 in dividends, representing a 0.00% dividend yield. Nubank reinvests its earnings into growth, and joining the Ibovespa does not change that strategy.

Will the financial sector gain a larger weighting in the index? Probably. According to BofA, the financial sector accounts for roughly 27% of the Ibovespa and could see its weighting increase with the inclusion of BDRs, given that three of the four eligible assets belong to the sector. Real-time index pricing is available on our Ibovespa Today page.

Key Milestones to Watch Through September 2027

1

ROXO34 liquidity on the B3: Only domestic trading volume counts toward the eligibility filter. If average volume falls significantly below October's R$ 206.6 million daily rate, index inclusion and the 1.52% weighting become less secure.

2

May 2027 portfolio previews: The B3's current list is a simulation. Official confirmation arrives via preliminary portfolio releases ahead of the rebalancing at half-weight.

3

Nubank's Q4 2026 delinquency rates: If defaults exceed the 7.3% reported in the third quarter, index-driven tailwinds will be overshadowed by mounting credit costs.

4

JBS margins in 2027: JBSS32's performance depends on the turning of the cattle cycle, not R$ 327 million in passive fund flows.

5

September 2027 rebalancing: This marks the final phase when BDRs enter the index at full weighting and institutional fund accumulation concludes.